Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Presenilin-1 Interferes with Protein Folding
3 November 1999. A report in the current Nature Cell Biology describes a mechanism by which presenilin-1 (PS-1) mutations can interfere with protein folding. Kazunori Imaizumi of Osaka University and colleagues suggest that this process underlies neurodegeneration in this form of familial Alzheimer's. In particular, the PS-1 mutations were found to interfere with a cell's unfolded protein response (UPR), a set of mechanisms designed to reduce the "stress" caused by the presence of unfolded proteins in the endoplasmic reticulum (ER). Among the mediators of the UPR are the molecule IRE1, which senses the stress on the ER, and various "chaperone" proteins that are induced by IRE1 and that facilitate protein folding.

In a series of in vitro experiments, Imaizumi and his colleagues found that under ER stress, cells expressing mutant PS-1 did not respond with the necessary increases of the chaperone protein GRP78 and were more likely to die. They traced this failure of GRP78 induction to interference by mutant PS-1 with autophosphorylation of the sensor molecule, IRE1. The researchers were also able to restore the UPR in mutant-PS-1-expressing cells and keep those cells alive by adding exogenous GRP78.

Finally, they looked for evidence of this process in humans. They found that levels of chaperone proteins were downregulated in specimens from the brains of Alzheimer's patients. The downregulation was greater in familial than in sporadic Alzheimer's specimens. IRE1 phosphorylation and GRP78 expression, say the authors, should thus be considered promising targets for therapies for both familial and sporadic Alzheimer's.-Hakon Heimer.

Reference:Katayama T, Imaizumi K, Sato N, Miyoshi K, Kudo T, Hitomi J, Morihara T, Yoneda T, Gomi F, Mori Y, Nakano Y, Takeda J, Tsuda T, Itoyama Y, Murayama O, Takashima A, St George-Hyslop P, Takeda M, Tohyama M. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Bio 1999 December;1:479-485. Abstract

 
Comments on News and Primary Papers
  Primary Papers: Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response.

Comment by:  Hiroshi Mori, ARF Advisor
Permalink

This is a nice cell biological study on AD. Perturbation at ER documented here is deeply related with all types of AD. Further investigation is welcome.

View all comments by Hiroshi Mori

  Primary Papers: Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response.

Comment by:  Nikolaos K. Robakis
Permalink

This is an important paper as it reports a new PS1 function and suggests a mechanism for cellular damage of the PS1 FAD mutations.

View all comments by Nikolaos K. Robakis
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad